mardi 26 janvier 2016

Onco Actu du 26 janvier 2016

1. Biologie

Gene often lost in childhood cancer crucial in cells' life or death decision [Karolinska Institutet]

2. Etiologie

Unraveling the Ties of Altitude, Oxygen and Lung Cancer [NY Times]

3.1 Tabac

Teens who vape are more likely to later try real cigarettes [STAT]

Cancer Research UK urges government to make big tobacco cough up [Cancer Research UK]

Teenagers who use e-cigarettes 'more likely to take up smoking', study finds [The Telegraph]

Teen vaping leads to teen smoking, new study suggests [LA Times]

4.10 Dép., diag. & prono. - FDA, EMA, NICE,...

Dako, an Agilent Technologies Company, Announces Expanded FDA Approval of Complementary Diagnostic Test to Include Melanoma [Dako]

4.12 Biopsies liquides

Are We Ready for a Blood Test for Cancer? [UCSF]

4.2 Dép., diag. & prono. - Génome

The genomics revolution and why we need to be smarter in our use of genetic data [The Institute of Cancer Research]

5.2 Pharma

US 'orphan status' for Immunocore's eye cancer drug [PharmaTimes]

5.2.1 Pharma - Partenariats

Broad Institute Genomic Services partners with Takeda Pharmaceuticals to offer genomic insight into the recently approved therapeutic NINLARO® (ixazomib) [Broad Institute of MIT and Harvard]

Merck, Affimed to test Hodgkin lymphoma combo [Pharma Times]

5.2.3 Pharma - économie

Big Pharma’s worst nightmare [The Guardian]

Soon-Shiong's NantCell raises another $57M for immuno-oncology work [FierceBiotech]

OncoMed Shares Fall After Discouraging News on Pancreatic Cancer Drug [Xconomy]

5.3.4 Traitements - AMM (FDA, EMA)

BMS' Opdivo evens the score in melanoma with two new FDA green lights [FiercePharma]

5.5 ASCO

Little Benefit With Targeted Tx in GI Cancers [Medpage Today]

6. Lutte contre les cancers

NCI-Match extends pause in enrollment [BioCentury]

Grand Challenge six: target cancer’s ‘super-controller’ [Cancer Research UK]

6.6 Publications

Top journal editors resist transparency [HealthNewsReview]

Journal Editors To Researchers: Show Everyone Your Clinical Data [NPR]

6.7 DMP, Big Data & applis

Big Pharma's bet on Big Data creates opportunities and risks [Reuters]

6.7.2 Applis

EU Looks to Improve Data Quality of mHealth Apps [RAPS]

6.9 Controverses

Could Harvard Medical School sell its naming rights for $1b? [STAT]